

浏览全部资源
扫码关注微信
中国中医科学院中医临床基础医学研究所,北京 100700
Received:07 August 2023,
Revised:2023-11-16,
Accepted:12 January 2024,
Published:15 April 2024
移动端阅览
张海力,刘斌,王巍力,等.《多维度多准则中成药综合评价技术指导原则》解读:评价指标权重[J].中国药房,2024,35(07):773-777.
ZHANG Haili,LIU Bin,WANG Weili,et al.Interpretation of the Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine:weighting of evaluation indicators[J].ZHONGGUO YAOFANG,2024,35(07):773-777.
张海力,刘斌,王巍力,等.《多维度多准则中成药综合评价技术指导原则》解读:评价指标权重[J].中国药房,2024,35(07):773-777. DOI: 10.6039/j.issn.1001-0408.2024.07.01.
ZHANG Haili,LIU Bin,WANG Weili,et al.Interpretation of the Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine:weighting of evaluation indicators[J].ZHONGGUO YAOFANG,2024,35(07):773-777. DOI: 10.6039/j.issn.1001-0408.2024.07.01.
目的
2
对《多维度多准则中成药综合评价技术指导原则》中“多维度多准则中成药综合评价技术指标体系(第一版)”的权重确定方法与结果进行详细报道和解读。
方法
2
根据层次分析法及专家赋值权重法所计算出的综合权重值进行归一化运算,获取指标的客观权重。
结果
2
当前中成药综合评价指标体系6个一级维度权重结果显示,其权重排序为有效维度>安全维度>标准维度>应用维度>科学维度>经济维度,权重值分别为0.281 0、0.268 5、0.195 8、0.107 3、0.096 1、0.051 3,与当前大多数研究结果一致。
结论
2
本指标体系权重确定过程科学合理、方法明确、解读清晰,值得进一步优化研究和广泛应用。
OBJECTIVE
2
To provide a detailed report and interpretation of the method and results for determining the weights of the technical indicators from the “multi-dimensional and multi-criteria comprehensive evaluation index system (first edition)” stated in
Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine
.
METHODS
2
Normalization calculations were performed on the comprehensive weight values calculated by the analytic hierarchy process and expert weighting method to obtain the objective weights of the indicators.
RESULTS
2
The weight results of the six primary dimensions in the current comprehensive evaluation indicator system of Chinese patent medicine showed effectiveness dimension>safety dimension>standard dimension>application dimension>scientific dimension>economic dimension, with weight values of 0.281 0, 0.268 5, 0.195 8, 0.107 3, 0.096 1 and 0.051 3 respectively, consistent with the results of most researches currently.
CONCLUSIONS
2
The process of weight determination in this indicator system is scientifically reasonable, with clear methods and clear interpretations, and is worthy of further optimization and widespread application.
童荣生 . 如何做好用好药品临床综合评价 [N ] . 健康报 , 2020-07-17 (5).
TONG R S . How to make good use of clinical comprehensive evaluation of drugs [N ] . Health Report , 2020-07-17 (5).
元唯安 , 张俊华 , 刘建平 , 等 . 中成药临床综合评价指南:2022年版试行 [J ] . 中国中药杂志 , 2023 , 48 ( 1 ): 256 - 264 .
YUAN W A , ZHANG J H , LIU J P , et al . Guideline for clinical comprehensive evaluation of Chinese patent medicine:2022 version [J ] . China J Chin Mater Med , 2023 , 48 ( 1 ): 256 - 264 .
程杰 , 关胜江 , 曹俊岭 , 等 . 医疗机构中成药遴选专家共识:第一版 [J ] . 中国药学杂志 , 2022 , 57 ( 18 ): 1580 - 1586 .
CHENG J , GUAN S J , CAO J L , et al . Consensus of experts in the selection of Chinese patent medicine in medical institutions:first edition [J ] . Chin Pharm J , 2022 , 57 ( 18 ): 1580 - 1586 .
张海力 , 焦丽雯 , 梁宁 , 等 . 基于综合评价方法的多维度多准则优势中成药综合评价指标体系构建研究 [J ] . 中国中医基础医学杂志 , 2021 , 27 ( 3 ): 403 - 406 .
ZHANG H L , JIAO L W , LIANG N , et al . Construction of multi dimension and multi criteria evaluation index system for superior Chinese patent medicines based on comprehensive evaluation method [J ] . J Basic Chin Med , 2021 , 27 ( 3 ): 403 - 406 .
中国中医科学院中医临床基础医学研究所 , 北京中医药大学东直门医院 , 中华医学会杂志社指南与标准研究中心 , 等 . 多维度多准则中成药综合评价技术指导原则 [J ] . 中国循证医学杂志 , 2022 , 22 ( 7 ): 751 - 755 .
Institute of Basic Research in Clinical Medicine , China Academy of Chinese Medical Sciences , Dongzhimen Hospital of Beijing University of Chinese Medicine , Guidelines and Standards Research Center of Chinese Medical Association Publishing House , et al . Guideline for multi-dimensional and multi-criteria comprehensive evaluation of Chinese patent medicine [J ] . Chin J Evid Based Med , 2022 , 22 ( 7 ): 751 - 755 .
张海力 , 梁宁 , 陈雅馨 , 等 . 多维度多准则中成药综合评价技术指导原则解读 [J ] . 中国循证医学杂志 , 2022 , 22 ( 7 ): 762 - 767 .
ZHANG H L , LIANG N , CHEN Y X , et al . Interpretation of the guideline for multi-dimensional and multi-criteria comprehensive evaluation for Chinese patent medicine [J ] . Chin J Evid Based Med , 2022 , 22 ( 7 ): 762 - 767 .
温浩 , 王巍力 , 张海力 , 等 . 多维度多准则中成药综合评价技术指导原则解读:评价模型的建立 [J ] . 中国循证医学杂志 , 2022 , 22 ( 10 ): 1196 - 1200 .
WEN H , WANG W L , ZHANG H L , et al . Interpretation of guideline for multi-dimensional and multi-criteria evaluation for Chinese patent medicine:establishment of an evaluation model [J ] . Chin J Evid Based Med , 2022 , 22 ( 10 ): 1196 - 1200 .
郭亚军 . 综合评价理论、方法与拓展 [M ] . 北京 : 科学出版社 , 2012 : 77 .
GUO Y J . Comprehensive evaluation theory,methods,and extensions [M ] . Beijing : Science Press , 2012 : 77 .
杜栋 , 庞庆华 . 现代综合评价方法与案例精选 [M ] . 4版 . 北京 : 清华大学出版社 , 2021 : 8 - 9 .
DU D , PANG Q H . Modern comprehensive evaluation methods and case selection [M ] . Version 4.Beijing : Tsinghua University Press , 2021 : 8 - 9 .
施能进 , 丁静 , 王刚 , 等 . 药品零售企业网售处方药风险及对策研究 [J ] . 中国药房 , 2023 , 34 ( 9 ): 1031 - 1037 .
SHI N J , DING J , WANG G , et al . Study on the risk and countermeasure of prescription drugs sold online by drug retail enterprises [J ] . China Pharm , 2023 , 34 ( 9 ): 1031 - 1037 .
张海力 . 多维度多准则中成药综合评价方法构建及应用研究 [D ] . 北京 : 中国中医科学院 , 2023 .
ZHANG H L . Development and application of a multi-dimensional and multi-criteria comprehensive evaluation for Chinese patent medicine [D ] . Beijing : China Academy of Chinese Medical Sciences , 2023 .
KARAYALCIN I I . The analytic hierarchy process:planning,priority setting,resource allocation [J ] . Eur J Oper Res , 1982 , 9 ( 1 ): 97 - 98 .
余进 , 陈维进 , 王弘 , 等 . 层次分析法在确定评估体系指标权重中的应用 [J ] . 中国医疗设备 , 2013 , 28 ( 12 ): 44 - 47 .
YU J , CHEN W J , WANG H , et al . Application of the analytic hierarchy process in establishing the weight values of PACS score system [J ] . China Med Devices , 2013 , 28 ( 12 ): 44 - 47 .
董名扬 , 陈朋军 , 王舒 , 等 . 应用层次分析模型构建药品临床综合评价指标体系与量化分级 [J ] . 中国药房 , 2023 , 34 ( 11 ): 1298 - 1301 .
DONG M Y , CHEN P J , WANG S , et al . Construction of drug clinical comprehensive evaluation index system and quantitative grading by using analytic hierarchy model [J ] . China Pharm , 2023 , 34 ( 11 ): 1298 - 1301 .
司天梅 , 王振 , 李凌江 . 抗抑郁药品临床综合评价专家共识 [J ] . 中国药房 , 2023 , 34 ( 13 ): 1547 - 1554 .
SI T M , WANG Z , LI L J . Expert consensus on comprehensive clinical evaluation of antidepressant drugs [J ] . China Pharm , 2023 , 34 ( 13 ): 1547 - 1554 .
0
Views
32
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
公网安备50010302001817